UCB reported EUR1.6B in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Alcon AG USD 728M 72M Sep/2026
Almirall EUR 80.45M 33.61M Jun/2026
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 539M 6M Sep/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Bayer EUR 1.62B 529M Sep/2026
Genmab DKK 401M 186M Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 505M 32M Sep/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.68B 82.6M Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Orion EUR 225.5M 33.6M Sep/2026
Recordati EUR 260.9M 4.3M Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
UCB EUR 1.6B 570M Dec/2025
Unibail Rodamco EUR 1.16B 143.2M Jun/2026